HONG KONG, Oct. 11 OrbusNeich today reported the completion of patient enrollment in a randomized clinical study of its Genous Bio-engineered R stent at 11 sites in China. The primary objective of the 180 patient, controlled study is ...
INDIANAPOLIS, Oct. 11 BioStorage Technologies, a global leader in sample management, cold chain logistics and biomaterial storage for the pharmaceutical and biotechnology industries, has expanded its sample management offerings to include ...
PALO ALTO, Calif., Oct. 11 Arable Corporation (www.arablecorp.com) has announced the launch of Arable Perform to bring unique CTMS technologies to the clinical trial industry. Whereas traditional CTMS systems have been costly and require ...
BOCA RATON, Fla., Oct. 11 Daniel Man, M.D., a renowned board-certified plastic surgeon, author, artist, and inventor, has retained Boca Raton-based, award-winning PR firm The Gab Group to market his line of esthetic services and skin ...
SAN DIEGO, Oct. 4 Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its APTIMA® Trichomonas vaginalis assay on the fully automated ...
ROCKVILLE, Md., Oct. 4 Human growth hormone can be used successfully to treat some symptoms of cystic fibrosis, but its impact on the disease itself remains unknown, according to a new report funded by HHS' Agency for Healthcare Research ...
NEW YORK, Oct. 4 Reportlinker.com announces that a new market research report is available in its catalogue: US Chiropractic Care Industry http:www.reportlinker.com/p0305156/US-Chiropractic-Care-Industry.html This report ...
NEW YORK, Oct. 4 Reportlinker.com announces that a new market research report is available in its catalogue: Global Soft Tissue Allografts Industry ...
SEOUL, South Korea, Oct. 4 CrystalGenomics, Inc. (Seoul, Korea) and CG Pharmaceuticals, Inc. (Emeryville, California), a drug discovery and development biopharmaceutical company, has announced that Dr. William Schmidt, its Vice President of ...
ALTOONA, Pa., Oct. 4 In response to the growing homecare and therapy markets, and the importance of "aging-in-place" as an alternative solution to institutionalized care, Delta Health Technologies, LLC ("Delta") today announced the ...
Vanderbilt’s Phase I trial of VU319 demonstrates promising results for Alzheimer’s and schizophrenia
Late-breaking research finds no survival benefit from autologous stem cell transplant in mantle cell lymphoma patients with undetectable MRD.
Hypovolemic phlebotomy, removing 10% of blood before liver surgery, can cut transfusion needs by 50%, offering a safe, cost-effective way to reduce surgery risks.
Felzartamab, an investigational antibody, reduces triggers linked to IgA nephropathy, an autoimmune kidney disease, suggesting lasting clinical benefits.
Discover how FarrSight ®-Twin technology utilizes digital twins to revolutionize cancer clinical trials by simulating patient responses.
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers